Latest News and Press Releases
Want to stay updated on the latest news?
Search Results
Everything
-
Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Market by Antibody Type, Medication Type, Application, End-User, and Region 2025-2033" report has been added to ...
-
Westford, USA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the cancer monoclonal antibodies market size will attain a value of USD 337.92 billion by 2031, with a CAGR of 18.4% over the...
-
Delhi, July 31, 2024 (GLOBE NEWSWIRE) -- Monoclonal antibody combination therapy represents a significant advancement in modern medicine, particularly in the treatment of cancer and autoimmune...
-
Ottawa, July 04, 2023 (GLOBE NEWSWIRE) -- According to Precedence Research, the cancer monoclonal antibodies market size will rise to USD 292.55 billion by 2030. The global cancer monoclonal...
-
Dublin, May 11, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2016-2023" report has been added to ResearchAndMarkets.com's offering.The Global...
-
New York, USA, April 26, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global cancer monoclonal antibodies market. According to the report, the global market is projected...
-
Portland, OR, March 20, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global cancer monoclonal antibodies market generated $55.6 billion in 2021, and is...
-
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Precision Cancer Therapeutics, 2022" report has been added to ResearchAndMarkets.com's offering. The analyst has watched the cancer treatment market...
-
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Conjugated Antibodies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Conjugated Antibodies in Oncology:...
-
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2015-2022" report has been added to ResearchAndMarkets.com's offering. The Cancer...